Mantle cell lymphoma (MCL) remains an incurable hematological malignancy with a median overall survival (OS) of 3–5 years. The clinical course can be extremely variable with some individuals demons...
No takes yet. Share an insight, caveat, or question.
Eve et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: